Advanced searches left 3/3

Carvedilol - Crossref

Summarized by Plex Scholar
Last Updated: 10 January 2023

* If you want to update the article please login/register

Effect of P-glycoprotein Inhibitor (Carvedilol) on Developmental Outcome Methotrexate are Given Alone and in Combination of Pregnant Rats

Before mating and after copulation, followed by approval of pregnancy, dosing in female groups during pregnancy and lactation periods was randomly administered carvedilol, 0. 36 mg/kg methotrexate, combined doses carvedilol+methotrexate, carvedilol, etc. The results of fertility index measurement in Cv-TG, MTX-TG, and Cv+MTX-TG were markedly lower than those obtained in Cv-TG, MTX-TG, and Cv+MTX-TG were significantly lower than those obtained in Cv-TG, MTX-TG, Cv-TG, and Cv+MTX-TG were significantly lower than those in Cv-TG, Cv-TG and Cv-MTX-TG and Cv-TG, TG, Cv-MTX-MTX-TG and Cv-TG and Cv-TG, TG and Cv-TG and Cv-TG and Cv-TG and Cv-TG-TG and Cv-TG and Cv-TG and Cv-TG and Cv-TG, TG and Cv-TG-TG-TG and Cv+MTX-MTX-TG, TG, X-TG-TG, X-TG, X-TG It has been reported that blocking P-gp by carvedilol in fetal and pups'u2019 tissue could increase methotrexate concentrations and increased methotrexate concentrations in fetal and pups, as a result of the increasing adverse effects of methotrexate in fetus and pups of the Cv+MTX-TG group, which may explain the current findings of the teratogenic study.

Source link: https://doi.org/10.30539/ijvm.v46i2.1410


Prediction of Hepatic Clearance of Stereoselective Metabolism of Carvedilol in Liver Microsomes and Hepatocytes of Sprague-Dawley and Cytochrome P450 2D-Deficient Dark Agouti Rats

Following intravenous injection of DA rats in DA rats, CAR concentrations were higher than those in SD rats. CLh's results from in vitro experiments using DA rat liver microsomes were different from those obtained from in vitro studies, according to CLh's expectations from in vitro experiments. In vitro CLh prediction using DA rat hepatocytes was almost identical to those found in vivo, but it was less than 10% in SD rats. The predicted CLh in vitro using hepatocytes correlated well with the observed CLtot in vivo, which is expected to be almost the same as CLh.

Source link: https://doi.org/10.18433/jpps30237


Hot Stage Microscopy-based Method for Determination of Particle Size in Reverse Engineering: Establishment of a Platform Technology Employing Carvedilol as a Model Drug

Aim: To develop a hot stage microscopy based method for particle size determination in reverse engineering and the establishment of a platform technology based on carvedilol as a model drug. Objective: This study was designed to establish a platform technology for determining particle size in reverse engineering using hot stage microscopy. Result: DSC technique helped to unwind information about qualitative as well as quantitative aspects of the formulation blend, which led to the elimination of the formulation blend. The HSM method used by the designer and manufacturer helped to establish the drug's particulate level properties. Conclusion: The study found that the two thermal methods DSC and HSM together could be used to reverse engineer a given formulation using a smaller sample size. In addition, this HSM-based particle size determination will give further insight into the decoding of an innovator product in a shorter period.

Source link: https://doi.org/10.2174/1573411018666220820095257


Carvedilol versus metoprolol succinate in the treatment of patients with heart failure with reduced ejection fraction and patients with acute myocardial infarction

Both drugs significantly reduce mortality risks and hospitalization, according to this report, which seeks the most appropriate beta-blocker for the treatment of patients with chronic heart failure and patients with acute myocardial infarction. The results of meta-analyzes, controlled trials comparing the efficacy of carvedilol and metoprolol succinate in the treatment of patients with heart failure with reduced ejection fraction and patients with acute myocardial infarction were reviewed. According to a meta-analysis of 2015 and 2017, carvedilol's effect on heart failure with reduced ejection fraction and patients with acute myocardial infarction was more effective than metoprolol succinate in heart failure with reduced ejection fraction and patients with acute myocardial infarction than metoprolol succinate, according to the study.

Source link: https://doi.org/10.15407/internalmed2021.01.036


Gαi is required for carvedilol-induced β1 adrenergic receptor β-arrestin biased signaling

Any other u03b2AR ligand screened or recruited G3b1 b1 i is not induced by any other ligand, nor is it mandatory for u03b2AR subtypes of the u03b2AR family. ' Our results point out that G03b1 i in u03b2-1 AR signaling may have previously unrecognized place in u03b2 1 AR signaling, implying that the theory of u03b2-arrestin-bias may have to be expanded to account for receptor specificity of receptor subtypes.

Source link: https://doi.org/10.1038/s41467-017-01855-z


Liquid Chromatography–High-Resolution Mass Spectrometry (LC–HRMS) Analysis Following Voluntary Carvedilol Poisoning in a Subject with Cirrhosis: A Case Report

103 g/L 24 h after ingestion, the results for the plasma concentration of carvedilol were 906 u00b5g/L 3 h after ingestion, 288 b5g/L 3 h after ingestion, 906 u00b5g/L 36 h after ingestion, and 103 %u00b5g/L 24 h after ingestion. The product, which was determined as the highest concentration ever measured for this drug, was 4. 8 h after ingestion, with linear and first order best describing the removal of the carvedilol. However, the patient was cirrhotic, and liver function was impaired by lowered Factor V and Prothrombin ratios, and liver function was impaired.

Source link: https://doi.org/10.1093/jat/bkac078


Anti-fibrotic impact of Carvedilol in a CCl-4 model of liver fibrosis via serum microRNA-200a/SMAD7 enhancement to bridle TGF-β1/EMT track

Hence, the new aim is to investigate the potential role of circulating miR-200a in Carvedilol's hepatic anti-fibrotic pathway. Male Wistar rats were randomized into CCl 4, CCl 4, and CCl 4 + Carvedilol. The circulating miR-200a has been over-expressed by Carvedilol to modulate epithelial transition markers. To reduce the pro-fibrogenic marker transforming growth factor u03b21 and the inflammatory markers, Carvedilol's increased SMAD7 gene expression and protein content in turn.

Source link: https://doi.org/10.1038/s41598-018-32309-1


Photobiomodulation therapy combined with carvedilol attenuates post-infarction heart failure by suppressing excessive inflammation and oxidative stress in rats

Abstract The post-myocardial infarction heart failure has been a huge burden even though new therapy is struggling to abrogate poor prognosis. However, it is also unknown if PBMt added to a common HF therapy provides additional cardiac remodeling in infarcted rats. This research was conducted to determine the combined carvedilol-drug and PBMt with low-level laser therapy results in HF. Carvedilol and PBMt took a similar approach in normalizing pulmonary congestion and LV end-diastolic pressure, attenuating LV dilation, and increasing LV systolic function, as normalizing respiratory congestion and LV end-diastolic pressure, normalizing pulmonary congestion and LV end-diastolic pressure, normalizing pulmonary congestion and LV end-diastolic function, In addition, the addition of PBMt to carvedilol-treated rats reduced myocardial hypertrophy and increased +dP/dt of LV. However, more importantly, the addition of PBMt to carvedilol reduced oxidized protein content and stimulated a high incidence of the anti-oxidant catalase enzyme, which was particularly noticeable. In a rat model of myocardial infarction, these results show that the use of PBMt plus carvedilol therapy results in a significant rise in HF.

Source link: https://doi.org/10.1038/s41598-019-46021-1


Drug screening with zebrafish visual behavior identifies carvedilol as a potential treatment for an autosomal dominant form of retinitis pigmentosa

Retinitis Pigmentosa is a common inherited retinal degeneration that affects approximately 1 in 4000 people worldwide. As a result, the larvae displayed a deficit in visual motor function under scotopic conditions. Since oxidative stress is presumed to play a role in RP progression, the diminished VMR was able to screen an ENZO SCREENWELL REDOX library. Carvedilol may specifically on rods because it directly affected the adrenergic pathway in the photoreceptor-like human Y79 cell line. Our results show that carvedilol can possibly be used to treat autosomal dominant RP patients since carvedilol is an FDA-approved drug.

Source link: https://doi.org/10.1038/s41598-021-89482-z


R-carvedilol, a potential new therapy for Alzheimer’s disease

In AD mouse models without effecting the accumulation of u00df -amyloid s, pharmacologically restricting ryanodine receptor 2 open time with the R-carvedilol enantiomer prevented and reversed neuronal hyperactivity, memory impairment, and neuron loss. R-carvedilol's findings show that it may be a promising new therapy for AD.

Source link: https://doi.org/10.3389/fphar.2022.1062495

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions